On this page you can find relevant researchs on drug-related health topics, including HIV, hepatitis C, drug and overdose prevention, harm reduction and drug treatment. You can also find our Clinical Guidelines.

Statement from the Asian Network of People who Use Drugs (ANPUD)
“People do not lose their human rights because they use or sell drugs” - UN High Commissioner for Human Rights Zeid Ra’ad Al Hussein
European Drug Report - Trends and Developments
The European Drug Report 2018: Trends and Developments provides a timely insight into Europe’s drug problems and responses. Our flagship report is built on a thorough review of European and national data that highlights emerging patterns and issues. This year it is accompanied online by 30 Country Drug Reports and resources containing full data arrays and graphics, allowing an overview for each country.
Advancing Drug Policy Reform: marking World Drug Day 2018
Video of Global Commissioners speaking out about the failure of prohibition and the additional harms created by repressive drug policies – the so-called “war on drugs”.
World Drug Report
Following last year's 20th anniversary edition, the World Drug Report 2018 is again presented in a special five-booklet format designed to enhance reader friendliness while maintaining the wealth of information contained within.
Doctor's street-level views could change the course of the opioid crisis
A staggering 64,000 people in the United States died in 2016 from drug overdoses, marking a 22 percent rise from the previous year of a cause of death that now annually exceeds those caused by motor vehicle accidents and gun violence.
From failed global drug prohibition to regulating the drug market
The failure of global drug prohibition, now increasingly acknowledged, demands urgent consideration of an alternative approach which is politically feasible while also respecting powerful market forces. Regulating as much of the drug market as possible is the only realistic option notwithstanding the political and other difficulties of achievement.
Exposure-Response Association Between Concurrent Opioid and Benzodiazepine Use and Risk of Opioid-Related Overdose in Medicare Part D Beneficiaries
How does the risk of overdose change with the number of days with concurrent opioid and benzodiazepine use?
The misuse of benzodiazepines among high-risk opioid users in Europe
This paper describes the impact of benzodiazepines misuse on the health and treatment of high-risk opioid users.
Drug consumption rooms: an overview of provision and evidence
Supervised drug consumption facilities, where illicit drugs can be used under the supervision of trained staff, have been operating in Europe for the last three decades. These facilities primarily aim to reduce the acute risks of disease transmission through unhygienic injecting, prevent drug-related overdose deaths and connect high-risk drug users with addiction treatment and other health and social services.
Primary care-based buprenorphine taper vs maintenance therapy for prescription opioid dependence: a randomized clinical trial.

Among patients dependent on prescription opioids, ongoing maintenance therapy using a legal opiate substitute (buprenorphine–naloxone) produced better outcomes than tapered withdrawal, with patients less likely to have used illicit opioids and considerably more likely to have remained in their allocated treatment.
Share this on: